Steven Keith Burke, SVP and Chief Medical Officer at Protara Therapeutics, holds 668.84K shares in Akebia Therapeutics (Ticker: AKBA), holds 128.25K shares in Protara Therapeutics (Ticker: TARA). Most recently, Steven Keith Burke Sold ― shares of Akebia Therapeutics on May 09, 2024 for an estimated value of 31.05K.
What is the percentage of profitable transactions made by Steven Keith Burke?
The percentage of profitable transactions made by Steven Keith Burke is 27%.
What is the average return per transaction made by Steven Keith Burke?
The average return per transaction made by Steven Keith Burke is -9.90%.
What stocks does Steven Keith Burke hold?
Steven Keith Burke holds: TARA, AKBA stocks.
What was Steven Keith Burke’s latest transaction?
Steven Keith Burke latest transaction was an Informative Sell of $31.05K.
What was Steven Keith Burke's most profitable transaction?
Steven Keith Burke’s most profitable transaction was an Informative Sell of AKBA stock on April 1, 2021. The return on the trade was 79.90%.
What is Steven Keith Burke's role in Protara Therapeutics?
Steven Keith Burke's role in Protara Therapeutics is SVP and Chief Medical Officer.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.